Section Editors

Mario Mandalà - Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy

Mario Mandalà

Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy

Dr. Mario Mandalà received his medical degree from the Faculty of Medicine, Catholic University of Rome, Italy. He is currently Head of the Melanoma Unit, Division of Oncology at the Papa Giovanni XXIII Hospital in Bergamo, Italy. He was recently appointed Coordinator of the Mucosal and Ocular Melanoma Section of the Italian Rare Cancers Network. From 2011 he has chaired the scientific and organising committees of the Clinical and Translational Research Working Group of the Italian Melanoma Intergroup (IMI). Since 2008, he has given major contributions to ESMO, AIOM and ISTH clinical practice guidelines on the management of venous thromboembolism and solid tumours.

Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

Jean-Jacques Grob discusses the role of adjuvant therapy in the treatment of melanoma at ESMO 2017. Support: The filming of this video was supported by Novartis. 1. What are the most significant unmet needs in melanoma treatment? And what are the greatest controversies? 0:07 2. What is the importance and optimal timing for treating in the adjuvant setting, and what impact will the adjuvant...
Ivan Marquez Rodas discusses the unmet treatment needs in melanoma, and the benefits of adjuvant therapy in the treatment of melanoma at ESMO 2017. Support: The filming of this video was supported by Novartis. 1. What are the most significant unmet needs in melanoma treatment? And what are the greatest controversies? 0:07 2. What is the importance and optimal timing for treating in the...
Dirk Schadendorf discusses the unmet need and importance, benefits and timing of adjuvant therapy in the treatment of melanoma at ESMO 2017. Support: The filming of this video was supported by Novartis. 1. What are the most significant unmet needs in melanoma treatment? And what are the greatest controversies? 0:07 2. What is the importance and optimal timing for treating in the adjuvant...

Melanomas INSIGHTS

The touchONCOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of oncology:

Insight
The Role of Interleukin in the Treatment of Malignant Melanoma and Renal Cell Carcinoma Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK